{
    "title": "Headaches decreased by Vitamin D, Magnesium etc. \u2013 Review",
    "slug": "headaches-decreased-by-vitamin-d-magnesium-etc-review",
    "aliases": [
        "/Headaches+decreased+by+Vitamin+D+Magnesium+etc+\u2013+Review+March+2022",
        "/13378"
    ],
    "tiki_page_id": 13378,
    "date": "2022-03-07",
    "categories": [
        "Magnesium",
        "Headache",
        "B12"
    ],
    "tags": [
        "B12",
        "Headache",
        "Magnesium",
        "anxiety",
        "autoimmune",
        "bariatric surgery",
        "bipolar disorder",
        "blood levels",
        "brain",
        "cancer",
        "cardiovascular",
        "child",
        "childhood cancer",
        "cognitive",
        "depression",
        "headache",
        "high dose",
        "intervention",
        "magnesium",
        "magnesium and cancer",
        "mood disorders",
        "multiple sclerosis",
        "neurological",
        "omega 3",
        "pain",
        "pediatric autoimmune",
        "rheumatoid arthritis",
        "statins",
        "therapeutic intervention",
        "trauma surgery",
        "vitamin d"
    ]
}


.{{< toc >}} 

---

#### Review on Headache Related to Dietary Supplements

Curr Pain Headache Rep . 2022 Mar 7. [doi: 10.1007/s11916-022-01019-9.PDF](https://doi.org/10.1007/s11916-022-01019-9.PDF) behind paywall

Shadi Ariyanfar # 1, Soodeh Razeghi Jahromi # 2, Mansoureh Togha 3, Zeinab Ghorbani 4

Purpose of review: The lifetime prevalence of headaches is 96%. Approximately 11% of the adult population worldwide has a migraine headache. Migraine is a complex disorder that is more than a simple headache. So far, many underlying mechanisms, i.e. inflammatory, vascular, neurogenic have been hypothesized. In recent years evidences proposed that an energy deficit due to changes in mitochondrial function contributes to migraine pathophysiology as an upstream disorder. Recent insights suggested that the coexistence of sensory-stimuli surplus and energy-reserve shortage activate the trigeminovascular system. Some nutrients are considered as essential elements in mitochondrial bioenergetics and some others are known as natural immuno-modulatory components. Also, evidence showed their beneficial effect in headache prophylaxis and treatment. In present study, we aimed to review the available data in this field.

Recent findings: Vitamin B group, magnesium, and Coenzyme Q10 (CoQ10) are well-known for their function in mitochondrial energy metabolism. On the other hand, studies support their beneficial role in controlling migraine headache symptoms. For instance, daily intake of 400-milligram  **riboflavin**  for 3 months resulted in more than 50% reduction in migraine attacks in more than half of the consumers. 

According to recent evidence, vitamin D and Omega-3 which are considered as famous immune-modulatory compounds are also reported to be effective in migraine prophylaxis. For example,  **every 22% reduction in migraine headache occurrence was reported for every 5 ng/ml rise in serum vitamin D** . Supplementation with vitamin B group, CoQ10, magnesium, vitamin D and Omega-3 could be considered as an effective, less costly strategy in headache/migraine prophylaxis.

---

##### References

1. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018;38(2):182–90. - PubMed

1. Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z.  **Migraine is first cause of disability in under 50s: will health politicians now take notice?** : Springer; 2018.

1. Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631–49. - PubMed

1. Altwaijri WA, Almazyad TA, Abuzaid YA, Alkhater JN, Ashmawi DM, Alnami GK, et al. Parental awareness of headaches among elementary school-aged children in Riyadh, Saudi Arabia: A cross-sectional studyz. J Family Med and Primary Care. 2021;10(4):1773–9. - PubMed - PMC

1. Ariyanfar S, Razeghi Jahromi S, Rezaeimanesh N, Togha M, Ghorbani Z, Khadem E, et al. Fruit and vegetable intake and odds of pediatric migraine. Nutr Food Sci. 2020;50(5):829–40.

1. Gross EC, Lisicki M, Fischer D, Sándor PS, Schoenen J. The metabolic face of migraine—from pathophysiology to treatment. Nat Rev Neurol. 2019;15(11):627–43. - PubMed

1. Lisicki M, Schoenen J. Metabolic treatments of migraine. Expert Rev Neurother. 2020;20(3):295–302. - PubMed

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine—current understanding and treatment. N Engl J Med. 2002;346(4):257–70. - PubMed

1. Hassan SA, Farooque U, Choudhry AS, Pillai B, Sheikh FN. Therapeutic implications of altered energy metabolism in migraine: a state-of-the-art review. Cureus. 2020;12(6).

1. Lodi R, Kemp G, Pierangeli G, Cortelli P, Iotti S, Radda G, et al. Quantitative analysis of skeletal muscle bioenergetics and proton efflux in migraine and cluster headache. J Neurol Sci. 1997;146(1):73–80. - PubMed

1. Chen S, Dong Z, Zhao Y, Sai N, Wang X, Liu H, et al. Homocysteine induces mitochondrial dysfunction involving the crosstalk between oxidative stress and mitochondrial pSTAT3 in rat ischemic brain. Sci Rep. 2017;7(1):1–12.

1. Yan TT, Li Q, Zhang XH, Wu WK, Sun J, Li L, et al. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling. Clin Exp Pharmacol Physiol. 2010;37(11):1071–7. - PubMed

1. Estourgie-van Burk GF, van der Kuy PHM, de Meij TG, Benninga MA, Kneepkens CMF. Intranasal treatment of  **vitamin**  B(12) deficiency in children. Eur J Pediatr. 2020;179(2):349–52. - PubMed

1. Chambers JC, Ueland PM, Wright M, Doré CJ, Refsum H, Kooner JS. Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects. Circ Res. 2001;89(2):187–92. - PubMed

1. Osorio-Bustamante D, Toro-Jiménez JC, Giraldo-Moreno N, Vargas-Henríquez LK, Machado-Alba JE, Castrillón-Spitia JD. Profilaxis En La Migraña: Descripción De La Prescripción En Un Primer Nivel De Colombia. Revista Ecuatoriana de Neurología. 2020;29:18–24.

1. Parohan M, Sarraf P, Javanbakht MH, Ranji-Burachaloo S, Djalali M. Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Neurosci. 2020;23(11):868–75. - PubMed

1. Rist PM, Buring JE, Cook NR, Manson JE, Kurth T. Effect of  **vitamin**  D and/or marine n-3 fatty acid supplementation on changes in migraine Frequency and Severity. Am J Med. 2021;134(6):756-62.e5. - PubMed

1. Soldavini J. Krause’s food & the nutrition care process. J Nutr Educ Behav. 2019;51(10):1225.

1. Kennedy DO. B  **vitamin** s and the brain: mechanisms, dose and efficacy—a review. Nutrients. 2016;8(2):68. - PubMed - PMC

1. Balasubramaniam S, Yaplito-Lee J.  **riboflavin**  metabolism: role in mitochondrial function. J Transl Genet Genom. 2020;4(4):285–306.

1. Aydin H, Bucak IH, Geyik M.  **vitamin**   **B12**  and folic acid levels in pediatric migraine patients. Acta Neurol Belg. 2020.

1. MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose  **riboflavin**  for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol. 2008;23(11):1300–4. - PubMed

1. Condò M, Posar A, Arbizzani A, Parmeggiani A.  **riboflavin**  prophylaxis in pediatric and adolescent migraine. J Headache Pain. 2009;10(5):361–5. - PubMed - PMC

1. Rahimdel A, Zeinali A, Yazdian-Anari P, Hajizadeh R, Arefnia E. Effectiveness of  **vitamin**   **B2**  versus sodium valproate in migraine prophylaxis: a randomized clinical trial. Electron Physician. 2015;7(6):1344–8. - PubMed - PMC

1. Maizels M, Blumenfeld A, Burchette R. A combination of  **riboflavin** ,  **magnesium** , and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–90. - PubMed

1. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose  **riboflavin**  in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50(2):466–70. - PubMed

1. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High-dose  **riboflavin**  treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004;11(7):475–7. - PubMed

1. Bruijn J, Duivenvoorden H, Passchier J, Locher H, Dijkstra N, Arts WF. Medium-dose  **riboflavin**  as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial. Cephalalgia. 2010;30(12):1426–34. - PubMed

1. Børte S, Zwart J-A, Skogholt AH, Gabrielsen ME, Thomas LF, Fritsche LG, et al. Mitochondrial genome-wide association study of migraine – the HUNT Study. Cephalalgia. 2020;40(6):625–34. - PubMed - PMC

1. Rajapakse T, Pringsheim T. Nutraceuticals in migraine: a summary of existing guidelines for use. Headache: The Journal of Head and Face Pain. 2016;56(4):808–16.

1. Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D’Amato CC. Role of  **magnesium** , coenzyme Q10,  **riboflavin** , and  **vitamin**   **B12**  in migraine prophylaxis. Vitam Horm. 2004;69:297–312. - PubMed

1. Bottiglieri T. Folate,  **vitamin**   **B12** , and S-adenosylmethionine. Psychiatr Clin North Am. 2013;36(1):1–13. - PubMed

1. Menon S, Nasir B, Avgan N, Ghassabian S, Oliver C, Lea R, et al. The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients. J Headache Pain. 2016;17(1):60. - PubMed - PMC

1. Lea R, Colson N, Quinlan S, Macmillan J, Griffiths L. The effects of  **vitamin**  supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet Genomics. 2009;19(6):422–8. - PubMed

1. Calik M, Aktas MS, Cecen E, Piskin IE, Ayaydın H, Ornek Z, et al. The association between serum  **vitamin**  B(12) deficiency and tension-type headache in Turkish children. Neurol Sci. 2018;39(6):1009–14. - PubMed

1. Togha M, Razeghi Jahromi S, Ghorbani Z, Martami F, Seifishahpar M. Serum  **vitamin**   **B12**  and methylmalonic acid status in migraineurs: a case-control study. Headache: The Journal of Head and Face Pain. 2019;59(9):1492–503.

1. Menon S, Lea RA, Roy B, Hanna M, Wee S, Haupt LM, et al. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to  **vitamin**  supplementation. Pharmacogenet Genomics. 2012;22(10):741–9. - PubMed

1. Askari G, Nasiri M, Mozaffari-Khosravi H, Rezaie M, Bagheri-Bidakhavidi M, Sadeghi O. The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized placebo-controlled, clinical trial. Nutrition (Burbank, Los Angeles County, Calif). 2017;38:74–9.

1. Sadeghi O, Nasiri M, Maghsoudi Z, Pahlavani N, Rezaie M, Askari G. Effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks in migraine patients with aura: A double-blind randomized clinical trial study in Iran. Iran J Neurol. 2015;14(2):74–80. - PubMed - PMC

1. Togha M, Rahmanzadeh R, Nematgorgani S, Yari Z, Razeghi Jahromi S, Refaeian F. Suppression of menstrual-related migraine attack severity using pyridoxine, thiamine, and cyanocobalamin: a quasi-experimental within-subject design. Arch Neurosci. 2020;7(3).

1. Liampas IN, Siokas V, Aloizou AM, Tsouris Z, Dastamani M, Aslanidou P, et al. Pyridoxine, folate and cobalamin for migraine: a systematic review. Acta Neurol Scand. 2020;142(2):108–20. - PubMed

1. Oedegaard KJ, Neckelmann D, Mykletun A, Dahl AA, Zwart JA, Hagen K, et al. Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia. 2006;26(1):1–6.

1. Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and  **vitamin**   **B12** . J Psychopharmacol. 2005;19(1):59–65. - PubMed

1. Dindo L, Recober A, Marchman JN, Turvey C, O’Hara MW. One-day behavioral treatment for patients with comorbid depression and migraine: a pilot study. Behav Res Ther. 2012;50(9):537–43. - PubMed - PMC

1. Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Res. 2006;40(5):445–53.

1. Rozen T, Oshinsky M, Gebeline C, Bradley K, Young W, Shechter A, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22(2):137–41. - PubMed

1. Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: effects on clinical features and inflammatory markers. Nutr Neurosci. 2019;22(9):607–15. - PubMed

1. Dalla Volta G, Carli D, Zavarise P, Ngonga G, Vollaro S. P026. Pilot study on the use of coenzyme Q10 in a group of patients with episodic migraine without aura. J Headache Pain. 2015;16(Suppl 1):A186. - PubMed - PMC

1. Hajihashemi P, Askari G, Khorvash F, Reza Maracy M, Nourian M. The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial. Cephalalgia. 2019;39(5):648–54. - PubMed

1. Guilbot A, Bangratz M, Ait Abdellah S, Lucas C. A combination of coenzyme Q10, feverfew and  **magnesium**  for migraine prophylaxis: a prospective observational study. BMC Complement Altern Med. 2017;17(1):433. - PubMed - PMC

1. Sun-Edelstein C, Mauskop A. Role of  **magnesium**  in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009;9(3):369–79. - PubMed

1. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous  **magnesium**  sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22(5):345–53. - PubMed

1. Assarzadegan F, Asgarzadeh S, Hatamabadi HR, Shahrami A, Tabatabaey A, Asgarzadeh M. Serum concentration of  **magnesium**  as an independent risk factor in migraine attacks: a matched case-control study and review of the literature. Int Clin Psychopharmacol. 2016;31(5):287–92. - PubMed

1. Talebi M, Savadi-Oskouei D, Farhoudi M, Mohammadzade S, Ghaemmaghamihezaveh S, Hasani A, et al. Relation between serum  **magnesium**  level and migraine attacks. Neurosciences (Riyadh, Saudi Arabia). 2011;16(4):320–3.

1. Assarzadegan F, Asadollahi M, Derakhshanfar H, Kashefizadeh A, Aryani O, Khorshidi M. Measuring Serum Level of Ionized  **magnesium**  in Patients with Migraine. Iran J Child Neurol. 2015;9(3):13. - PubMed - PMC

1. Samaie A, Asghari N, Ghorbani R, Arda J. Blood  **magnesium**  levels in migraineurs within and between the headache attacks: a case control study. Pan Afr Med J. 2012;11:46. - PubMed - PMC

1. Baratloo A, Mirbaha S, Delavar Kasmaei H, Payandemehr P, Elmaraezy A, Negida A. Intravenous caffeine citrate vs  **magnesium**  sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. Korean J Pain. 2017;30(3):176–82. - PubMed - PMC

1. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G.  **magnesium**  prophylaxis of menstrual migraine: effects on intracellular  **magnesium** . Headache. 1991;31(5):298–301. - PubMed

1. Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral  **magnesium** : results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257–63. - PubMed

1. Koseoglu E, Talaslioglu A, Gonul AS, Kula M. The effects of  **magnesium**  prophylaxis in migraine without aura. Magnes Res. 2008;21(2):101–8. - PubMed

1. Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, Talebi M, Nikniaz Z, Safaiyan A. The effects of  **magnesium** , L-carnitine, and concurrent  **magnesium** -L-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res. 2012;150(1–3):42–8. - PubMed

1. Choi H, Parmar N. The use of intravenous  **magnesium**  sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med. 2014;21(1):2–9. - PubMed

1. Dolati S, Rikhtegar R, Mehdizadeh A, Yousefi M. The role of  **magnesium**  in pathophysiology and migraine treatment. Biol Trace Elem Res. 2020;196(2):375–83. - PubMed

1. Vieth R.  **vitamin**  D supplementation, 25-hydroxy **vitamin**  D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842–56. - PubMed

1. Togha M, Razeghi Jahromi S, Ghorbani Z, Martami F, Seifishahpar M. Serum  **vitamin**  D status in a group of migraine patients compared with healthy controls: a case-control study. Headache. 2018;58(10):1530–40. - PubMed

1. Ghorbani Z, Togha M, Rafiee P, Ahmadi ZS, Rasekh Magham R, Djalali M, et al.  **vitamin**  D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial. Neurol Sci. 2020;41(5):1183–92. - PubMed

1. Mahmoud AM, Szczurek M, Hassan C, Masrur M, Gangemi A, Phillips SA.  **vitamin**  D improves nitric oxide-dependent vasodilation in adipose tissue arterioles from bariatric surgery patients. Nutrients. 2019;11(10):2521. - PMC

1. Alamro AA, Alsulami EA, Almutlaq M, Alghamedi A, Alokail M, Haq SH. Therapeutic potential of  **vitamin**  D and curcumin in an in vitro model of alzheimer disease. J Cent Nerv Syst Dis. 2020;12:1179573520924311. - PubMed - PMC

1. Iannacchero R, Costa A, Squillace A, Gallelli L, Cannistrà U, De Sarro G. P060.  **vitamin**  D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients. J Headache Pain. 2015;16(Suppl 1):A184-A. - PubMed - PMC

1. Prakash S, Kumar M, Belani P, Susvirkar A, Ahuja S. Interrelationships between chronic tension-type headache, musculoskeletal pain, and  **vitamin**  D deficiency: Is osteomalacia responsible for both headache and musculoskeletal pain? Ann Indian Acad Neurol. 2013;16(4):650–8. - PubMed - PMC

1. Song TJ, Chu MK, Sohn JH, Ahn HY, Lee SH, Cho SJ. Effect of citamin D deficiency on the frequency of headaches in migraine. J Clin Neurol (Seoul, Korea). 2018;14(3):366–73.

1. Knutsen KV, Brekke M, Gjelstad S, Lagerløv P.  **vitamin**  D status in patients with musculoskeletal pain, fatigue and headache: A cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scand J Prim Health Care. 2010;28(3):166–71. - PubMed - PMC

1. Donmez A, Orun E, Sonmez FM.  **vitamin**  D status in children with headache: a case-control study. Clin Nutr ESPEN. 2018;23:222–7. - PubMed

1. Rapisarda L, Mazza MR, Tosto F, Gambardella A, Bono F, Sarica A. Relationship between severity of migraine and  **vitamin**  D deficiency: a case-control study. Neurol Sci. 2018;39(Suppl 1):167–8. - PubMed

1. Kjaergaard M, Eggen AE, Mathiesen EB, Jorde R. Association between headache and serum 25-hydroxy **vitamin**  D: the Tromsø Study: Tromsø 6. Headache. 2012;52(10):1499–505. - PubMed

1. Buettner C, Burstein R. Association of statin use and risk for severe headache or migraine by serum  **vitamin**  D status: a cross-sectional population-based study. Cephalalgia. 2015;35(9):757–66. - PubMed

1. Celikbilek A, Gocmen AY, Zararsiz G, Tanik N, Ak H, Borekci E, et al. Serum levels of  **vitamin**  D,  **vitamin**  D-binding protein and  **vitamin**  D receptor in migraine patients from central Anatolia region. Int J Clin Pract. 2014;68(10):1272–7. - PubMed

1. Mottaghi T, Khorvash F, Askari G, Maracy MR, Ghiasvand R, Maghsoudi Z, et al. The relationship between serum levels of  **vitamin**  D and migraine. J Res Med Sci. 2013;18(Suppl 1):S66-70. - PubMed - PMC

1. Virtanen JK, Giniatullin R, Mäntyselkä P, Voutilainen S, Nurmi T, Mursu J, et al. Low serum 25-hydroxy **vitamin**  D is associated with higher risk of frequent headache in middle-aged and older men. Sci Rep. 2017;7:39697. - PubMed - PMC

1. Mottaghi T, Askari G, Khorvash F, Maracy MR. Effect of  **vitamin**  D supplementation on symptoms and C-reactive protein in migraine patients. J Res Med Sci. 2015;20(5):477–82. - PubMed - PMC

1. Knutsen KV, Madar AA, Brekke M, Meyer HE, Natvig B, Mdala I, et al. Effect of  **vitamin**  D on musculoskeletal pain and headache: a randomized, double-blind, placebo-controlled trial among adult ethnic minorities in Norway. Pain. 2014;155(12):2591–8. - PubMed

1. Zandifar A, Masjedi SS, Banihashemi M, Asgari F, Manouchehri N, Ebrahimi H, et al.  **vitamin**  D status in migraine patients: a case-control study. Biomed Res Int. 2014;2014:514782. - PubMed - PMC

1. Ghorbani Z, Rafiee P, Fotouhi A, Haghighi S, Rasekh Magham R, Ahmadi ZS, et al. The effects of  **vitamin**  D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. J Headache Pain. 2020;21(1):22. - PubMed - PMC

1. Gazerani P, Fuglsang R, Pedersen JG, Sørensen J, Kjeldsen JL, Yassin H, et al. A randomized, double-blinded, placebo-controlled, parallel trial of  **vitamin**  D(3) supplementation in adult patients with migraine. Curr Med Res Opin. 2019;35(4):715–23. - PubMed

1. Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA, et al. Simvastatin and  **vitamin**  D for migraine prevention: a randomized, controlled trial. Ann Neurol. 2015;78(6):970–81. - PubMed - PMC

1. Cayir A, Turan MI, Tan H. Effect of  **vitamin**  D therapy in addition to amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res. 2014;47(4):349–54. - PubMed - PMC

1. Helde-Frankling M, Björkhem-Bergman L.  **vitamin**  D in pain management. Int J Mol Sci. 2017;18(10).

1. Yong WC, Sanguankeo A, Upala S. Effect of  **vitamin**  D supplementation in chronic widespread pain: a systematic review and meta-analysis. Clin Rheumatol. 2017;36(12):2825–33. - PubMed

1. de Oliveira DL, Hirotsu C, Tufik S, Andersen ML. The interfaces between  **vitamin**  D, sleep and pain. J Endocrinol. 2017;234(1):R23-r36. - PubMed

1. Wu Z, Malihi Z, Stewart AW, Lawes CM, Scragg R. Effect of  **vitamin**  D supplementation on pain: a systematic review and meta-analysis. Pain Physician. 2016;19(7):415–27. - PubMed

1. Cardia L, Calapai F, Mondello C, Quattrone D, Elisa Sorbara E, Mannucci C, et al. Clinical use of omega-3 fatty acids in migraine: a narrative review. Medicine. 2020;99(42):e22253. - PubMed - PMC

1. Soveyd N, Abdolahi M, Bitarafan S, Tafakhori A, Sarraf P, Togha M, et al. Molecular mechanisms of omega-3 fatty acids in the migraine headache. Iran J Neurol. 2017;16(4):210–7. - PubMed - PMC

1. Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay JM, et al. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia. 2001;21(8):818–22. - PubMed

1. Castaño G, Arruzazabala ML, Fernández L, Mas R, Carbajal D, Molina V, et al. Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: a randomized, double-blind clinical study. Curr Ther Res Clin Exp. 2006;67(3):174–92. - PubMed - PMC

1. Patrick RP, Ames BN.  **vitamin**  D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015;29(6):2207–22. - PubMed

1. Abdolahi M, Tafakhori A, Togha M, Okhovat AA, Siassi F, Eshraghian MR, et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics. 2017;69(6):371–8. - PubMed

1. Sawyer Q, Vesci B, McLeod TC. Physical activity and intermittent postconcussion symptoms after a period of symptom-limited physical and cognitive rest. J Athl Train. 2016;51(9):739–42. - PubMed - PMC

1. Jia Q, Ivanov I, Zlatev ZZ, Alaniz RC, Weeks BR, Callaway ES, et al. Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. Br J Nutr. 2011;106(4):519–29. - PubMed - PMC

1. Mirza M, Volz C, Karlstetter M, Langiu M, Somogyi A, Ruonala MO, et al. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PLoS One. 2013;8(10):e75963. - PubMed - PMC

1. Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: a randomized single-blind clinical trial. Iran J Neurol. 2012;11(1):21–4. - PubMed - PMC